Literature DB >> 11553225

Telomerase activity in small cell esophageal carcinoma.

V Chow1, S Law, K Y Lam, J M Luk, J Wong.   

Abstract

Small cell carcinoma of the esophagus is a rare and aggressive malignant tumor. Telomerase activation is common in human cancers. There is a lack of data on telomerase activity in esophageal small cell cancers. The present report studied the role of telomerase activity in esophageal small cell carcinoma. The clinicopathologic data of five patients with small cell carcinoma of the esophagus who underwent primary surgical treatment between 1991 and 2000 were studied. Telomeric repeat amplification protocol assays were used to investigate telomerase activity in these tumors. The proliferative activity (MIB-1) and p53 expression of these tumors were also studied using immunohistochemistry and correlated with the telomerase activity. All five small cell carcinomas showed detectable telomerase activity in the primary tumor. Two out of the five morphologically normal esophageal mucosae adjacent to the primary tumor had detectable telomerase activity. There was no correlation between the p53 expression, tumor stage, survival of patients, and the presence of telomerase activity. High MIB-1 expression in esophageal small cell carcinomas was associated with high telomerase activity. Telomerase activation is common in small cell carcinoma of the esophagus. This fact may find application in anti-telomerase treatment for this aggressive tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553225     DOI: 10.1046/j.1442-2050.2001.00172.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  A complete response in small cell carcinoma of the esophagus treated by s-1/cisplatin combined chemotherapy and radiotherapy.

Authors:  Masatsugu Hiraki; Masayuki Tanaka; Seiji Sato; Keita Kai; Kiyoto Morito; Kiichiro Kobayashi; Hirokazu Noshiro; Osamu Tokunaga; Kohji Miyazaki
Journal:  J Gastrointest Cancer       Date:  2010-12

Review 2.  Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management.

Authors:  Dimitrios Schizas; Aikaterini Mastoraki; George I Kirkilesis; Athanasios D Sioulas; Ioannis S Papanikolaou; Evangelos P Misiakos; Nikolaos Arkadopoulos; Theodore Liakakos
Journal:  J Gastrointest Cancer       Date:  2017-12

Review 3.  Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.

Authors:  Emma Elizabeth Ilett; Seppo W Langer; Ingrid Holst Olsen; Birgitte Federspiel; Andreas Kjær; Ulrich Knigge
Journal:  Diagnostics (Basel)       Date:  2015-04-08

4.  Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus.

Authors:  Kaikai Zhao; Zhaoqin Huang; Youjiao Si; Liangchao Sun; Jinming Yu; Xiangjiao Meng
Journal:  Cancer Manag Res       Date:  2021-01-25       Impact factor: 3.989

5.  Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases.

Authors:  Dina El Demellawy; Mahmoud A Khalifa; Nadia Ismiil; Shun Wong; Zeina Ghorab
Journal:  Diagn Pathol       Date:  2007-09-05       Impact factor: 2.644

6.  Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.

Authors:  Bingwen Zou; Tao Li; Qiang Zhou; Daiyuan Ma; Yongshun Chen; Meijuan Huang; Feng Peng; Yong Xu; Jiang Zhu; Zhenyu Ding; Lin Zhou; Jin Wang; Li Ren; Min Yu; Youling Gong; Yanying Li; Longqi Chen; You Lu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  Identification of Novel FAM134B (JK1) Mutations in Oesophageal Squamous Cell Carcinoma.

Authors:  Md Hakimul Haque; Vinod Gopalan; Kwok-Wah Chan; Muhammad J A Shiddiky; Robert Anthony Smith; Alfred King-Yin Lam
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.